Literature DB >> 8806283

Global status of hepatitis B immunisation.

M A Kane1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8806283     DOI： 10.1016/S0140-6736(05)65598-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  35 in total

1.  Relation between experimental and non-experimental study designs. HB vaccines: a case study.

Authors:  T Jefferson; V Demicheli
Journal:  J Epidemiol Community Health       Date:  1999-01       Impact factor: 3.710

2.  New and not so new vaccines.

Authors:  T Jefferson
Journal:  BMJ       Date:  1996-09-28

Review 3.  Potential mechanisms of hepatitis B virus induced liver injury.

Authors:  Mohd Suhail; Hany Abdel-Hafiz; Ashraf Ali; Kaneez Fatima; Ghazi A Damanhouri; Esam Azhar; Adeel Ga Chaudhary; Ishtiaq Qadri
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

4.  Epidemiology of hepatitis B virus infection in Albania.

Authors:  Bashkim Resuli; Skerdi Prifti; Bledar Kraja; Tatjana Nurka; Mimoza Basho; Edita Sadiku
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

5.  A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population.

Authors:  C O'Leary; Z Hong; F Zhang; M Dawood; G Smart; K Kaita; J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-12       Impact factor: 3.267

6.  Three decades of hepatitis B control with vaccination.

Authors:  Liliane C Meireles; Rui Tato Marinho; Pierre Van Damme
Journal:  World J Hepatol       Date:  2015-08-28

7.  Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Authors:  M Lu; G Hilken; J Kruppenbacher; T Kemper; R Schirmbeck; J Reimann; M Roggendorf
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogue.

Authors:  A J Nicoll; D L Colledge; J J Toole; P W Angus; R A Smallwood; S A Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

9.  Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.

Authors:  E Lin; C Luscombe; D Colledge; Y Y Wang; S Locarnini
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Immune Augmentation of Single Contact Hepatitis B Vaccine by Using PLGA Microspheres as an Adjuvant.

Authors:  S M Sivakumar; N Sukumaran; R Murugesan; T S Shanmugarajan; J Anbu; L Sivakumar; B Anilbabu; G Srinivasarao; V Ravichandran
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.